Transaction Update: AAM Stockholders Approve Proposed Combination
DETROIT, July 15, 2025 /PRNewswire/ -- American Axle & Manufacturing Holdings, Inc. ("AAM"), (NYSE: AXL) today announced that at a...
FORT WAYNE, Ind., July 15, 2025 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) will release its second quarter 2025 earnings at 8:00 am ET on Tuesday, July 29, 2025. A conference call to review earnings and other developments in the business will commence at 9:00 am ET. The second quarter 2025 earnings call will be available via a live webcast. The webcast will be available in a listen only mode by going to:
SINGAPORE, July 15, 2025 /PRNewswire/ -- HashKey OTC Global, an OTC trading platform under HashKey Group, announced today that in the first 6 months...
DELRAY BEACH, Fla., July 14, 2025 /PRNewswire/ -- The report "Cast Elastomers Market by Type (Hot Cast Elastomers and Cold Cast Elastomers), End-use Industry...
DELRAY BEACH, Fla., July 14, 2025 /PRNewswire/ -- The report "Cast Elastomers Market by Type (Hot Cast Elastomers and Cold Cast Elastomers), End-use Industry...
The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.
The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.
HOUSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that its board of directors has declared a quarterly cash dividend of $1.00 per common share, or $4.00 per common share on an annualized basis, for the second quarter of 2025. This cash dividend will be paid August 15, 2025 on all outstanding common shares to holders of record as of the close of business on July 31, 2025.
BETHESDA, Md., July 10, 2025 (GLOBE NEWSWIRE) -- Elme Communities (the “Company” or “Elme”) (NYSE:ELME), a value-oriented multifamily owner and operator, will release second quarter earnings results after market close on Tuesday, August 5, 2025. A conference call to discuss these results will be conducted on Wednesday, August 6, 2025, at 10:00 am ET. Conference call and webcast access information is as follows:
MONTRÉAL, July 10, 2025 /CNW/ -- Commerce Ressources Corp. (TSXV: CCE, FSE: D7H0, OTCQX: CMRZF) is pleased to announce key management appointments as it steps...
SINGAPORE, July 10, 2025 /PRNewswire/ -- Trina Storage, the energy storage division of global solar leader Trinasolar, has reached a significant milestone with more than...